• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Lifestyle and pharmacological approaches to weight loss: efficacy and safety.减肥的生活方式和药物治疗方法:疗效与安全性。
J Clin Endocrinol Metab. 2008 Nov;93(11 Suppl 1):S81-8. doi: 10.1210/jc.2008-1294.
2
Medical therapy for obesity.肥胖症的医学治疗
Mt Sinai J Med. 2010 Sep-Oct;77(5):407-17. doi: 10.1002/msj.20207.
3
[Pharmacological therapy of obesity].[肥胖症的药物治疗]
G Ital Cardiol (Rome). 2008 Apr;9(4 Suppl 1):83S-93S.
4
Combining behavioral and pharmacological treatments for obesity.结合行为疗法和药物疗法治疗肥胖症。
Obes Res. 2002 Jun;10(6):560-74. doi: 10.1038/oby.2002.77.
5
Treatment modalities of obesity: what fits whom?肥胖的治疗方式:哪种适合谁?
Diabetes Care. 2008 Feb;31 Suppl 2:S269-77. doi: 10.2337/dc08-s265.
6
Weight loss in obese Mexican Americans treated for 1-year with orlistat and lifestyle modification.使用奥利司他并结合生活方式改变对肥胖墨西哥裔美国人进行为期1年治疗后的体重减轻情况。
Int J Obes Relat Metab Disord. 2003 Dec;27(12):1486-93. doi: 10.1038/sj.ijo.0802439.
7
Exploring synergies in the treatment of obesity.探索肥胖症治疗中的协同作用。
Postgrad Med. 2001 Jun;109(6 Suppl):29-33. doi: 10.3810/pgm.06.2001.suppl14.76.
8
Weight loss strategies for treatment of obesity.肥胖治疗的体重减轻策略。
Prog Cardiovasc Dis. 2014 Jan-Feb;56(4):465-72. doi: 10.1016/j.pcad.2013.09.005. Epub 2013 Oct 11.
9
[The pharmacological treatment of obesity: past, present and future].[肥胖症的药物治疗:过去、现在与未来]
Orv Hetil. 2012 Mar 11;153(10):363-73. doi: 10.1556/OH.2012.29317.
10
Weight loss medications--where do they fit in?减肥药物——它们在其中处于什么位置?
Aust Fam Physician. 2006 Aug;35(8):576-9.

引用本文的文献

1
Utilization of Low-Dose Phentermine for Weight Loss Prior to Metabolic and Bariatric Surgery: A Prospective, Randomized, and Placebo-Controlled Trial.代谢和减重手术前使用低剂量苯丁胺减重:一项前瞻性、随机、安慰剂对照试验
Obes Sci Pract. 2025 Jan 17;11(1):e70043. doi: 10.1002/osp4.70043. eCollection 2025 Feb.
2
Finding of situs inversus in endoscopic sleeve gastroplasty: Case report.内镜袖状胃成形术中发现内脏反位:病例报告。
Int J Surg Case Rep. 2025 Jan;126:110727. doi: 10.1016/j.ijscr.2024.110727. Epub 2024 Dec 9.
3
The Mechanism of Leptin Resistance in Obesity and Therapeutic Perspective.肥胖症中瘦素抵抗的机制与治疗展望。
Adv Exp Med Biol. 2024;1460:463-487. doi: 10.1007/978-3-031-63657-8_16.
4
Anti-obesity and metabolic benefits of metformin: Comparison of different delivery routes.二甲双胍的抗肥胖及代谢益处:不同给药途径的比较
J Drug Deliv Sci Technol. 2024 Jan;91. doi: 10.1016/j.jddst.2023.105110. Epub 2023 Nov 15.
5
Management of hyperglycaemia in people with obesity.肥胖人群的高血糖管理。
Clin Med (Lond). 2023 Jul;23(4):364-371. doi: 10.7861/clinmed.2023-0135.
6
Phentermine-Induced Acute Kidney Injury Secondary to Uncontrolled Hypertension in a Patient with Weight Regain Post-bariatric Surgery.减肥手术后体重反弹患者因未控制的高血压继发芬特明所致急性肾损伤
Obes Surg. 2021 Aug;31(8):3874-3879. doi: 10.1007/s11695-021-05438-2. Epub 2021 Apr 22.
7
Anti-obesity potential of seed extract and lycopene on high fat diet induced obesity in male Sprauge Dawely rats.种子提取物和番茄红素对高脂饮食诱导的雄性斯普拉格-道利大鼠肥胖的抗肥胖潜力
Saudi J Biol Sci. 2020 Oct;27(10):2733-2746. doi: 10.1016/j.sjbs.2020.06.026. Epub 2020 Jun 23.
8
Pharmacogenetics of amfepramone in healthy Mexican subjects reveals potential markers for tailoring pharmacotherapy of obesity: results of a randomised trial.健康墨西哥受试者中美苯丙醇胺的药物遗传学研究揭示了针对肥胖症药物治疗的潜在标志物:一项随机试验的结果。
Sci Rep. 2019 Nov 28;9(1):17833. doi: 10.1038/s41598-019-54436-z.
9
Anti-obesity activity of OBEX is regulated by activation of thermogenesis and decreasing adiposity gain.OBEX 的抗肥胖活性是通过激活产热和减少脂肪堆积来调节的。
Sci Rep. 2018 Nov 21;8(1):17155. doi: 10.1038/s41598-018-34840-7.
10
Association of weight loss with improved disease activity in patients with rheumatoid arthritis: A retrospective analysis using electronic medical record data.类风湿关节炎患者体重减轻与疾病活动改善的关联:一项使用电子病历数据的回顾性分析。
Int J Clin Rheumtol. 2018;13(1):1-10. doi: 10.4172/1758-4272.1000154.

本文引用的文献

1
Protein, weight management, and satiety.蛋白质、体重管理与饱腹感。
Am J Clin Nutr. 2008 May;87(5):1558S-1561S. doi: 10.1093/ajcn/87.5.1558S.
2
Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease: the STRADIVARIUS randomized controlled trial.利莫那班对腹型肥胖合并冠状动脉疾病患者动脉粥样硬化进展的影响:STRADIVARIUS随机对照试验
JAMA. 2008 Apr 2;299(13):1547-60. doi: 10.1001/jama.299.13.1547. Epub 2008 Apr 1.
3
Dietary adherence and weight loss success among overweight women: results from the A TO Z weight loss study.超重女性的饮食依从性与减肥成功情况:A到Z减肥研究结果
Int J Obes (Lond). 2008 Jun;32(6):985-91. doi: 10.1038/ijo.2008.8. Epub 2008 Feb 12.
4
Serotonin 5-HT2C receptor agonist promotes hypophagia via downstream activation of melanocortin 4 receptors.血清素5-HT2C受体激动剂通过下游激活黑皮质素4受体促进食欲减退。
Endocrinology. 2008 Mar;149(3):1323-8. doi: 10.1210/en.2007-1321. Epub 2007 Nov 26.
5
Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials.减肥药物利莫那班的疗效与安全性:随机试验的荟萃分析
Lancet. 2007 Nov 17;370(9600):1706-13. doi: 10.1016/S0140-6736(07)61721-8.
6
Long term pharmacotherapy for obesity and overweight: updated meta-analysis.肥胖与超重的长期药物治疗:更新的荟萃分析
BMJ. 2007 Dec 8;335(7631):1194-9. doi: 10.1136/bmj.39385.413113.25. Epub 2007 Nov 15.
7
Meta-analysis: the effect of dietary counseling for weight loss.荟萃分析:饮食咨询对减肥的影响
Ann Intern Med. 2007 Jul 3;147(1):41-50. doi: 10.7326/0003-4819-147-1-200707030-00007.
8
Pharmacological treatment of the overweight patient.超重患者的药物治疗。
Pharmacol Rev. 2007 Jun;59(2):151-84. doi: 10.1124/pr.59.2.2.
9
Effects of a low-glycemic load vs low-fat diet in obese young adults: a randomized trial.低血糖负荷饮食与低脂饮食对肥胖青年成年人的影响:一项随机试验。
JAMA. 2007 May 16;297(19):2092-102. doi: 10.1001/jama.297.19.2092.
10
Effects of different doses of physical activity on cardiorespiratory fitness among sedentary, overweight or obese postmenopausal women with elevated blood pressure: a randomized controlled trial.不同剂量体育活动对久坐不动、超重或肥胖且血压升高的绝经后女性心肺适能的影响:一项随机对照试验
JAMA. 2007 May 16;297(19):2081-91. doi: 10.1001/jama.297.19.2081.

减肥的生活方式和药物治疗方法:疗效与安全性。

Lifestyle and pharmacological approaches to weight loss: efficacy and safety.

作者信息

Bray George A

机构信息

Pennington Biomedical Research Center, Baton Rouge, Louisiana 70808, USA.

出版信息

J Clin Endocrinol Metab. 2008 Nov;93(11 Suppl 1):S81-8. doi: 10.1210/jc.2008-1294.

DOI:10.1210/jc.2008-1294
PMID:18987274
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2585762/
Abstract

CONTEXT

Obesity results from a prolonged small positive energy balance, and its treatment needs to reverse this imbalance.

EVIDENCE ACQUISITION

Citations retrieved from PubMed and The Handbook of Obesity 2008 were selected to illustrate the points.

EVIDENCE SYNTHESIS

Many different diets have been tried to treat obesity, and weight loss occurs with all of them. There is currently no evidence that clearly supports a superiority of one macronutrient composition for diets used for weight loss. The principal effect seems to be the degree of adherence to the prescribed calorie reduction. Lifestyle strategies to modify eating behavior can be used in individual counseling sessions or in groups, both of which are important in helping patients modify their patterns of eating. Physical activity is particularly important in helping patients maintain a weight loss once achieved and is less valuable for weight loss itself. Food intake is controlled through many different mechanisms, but only a few drugs have been developed that tap these mechanisms. Orlistat, which blocks intestinal lipase, is one; sibutramine, a serotonin-norepinephrine reuptake inhibitor, is a second. Surgical approaches provide the most dramatic weight loss and have been demonstrated to reduce long-term mortality and reduce the incidence of diabetes.

CONCLUSIONS

Weight loss can be achieved by many methods, but the surgical procedures appear to be the most durable.

摘要

背景

肥胖是由长期的微小正能量平衡导致的,其治疗需要扭转这种失衡。

证据收集

从PubMed和《2008年肥胖手册》中检索到的文献被选来说明这些观点。

证据综合

人们尝试了许多不同的饮食方法来治疗肥胖,所有这些方法都能实现体重减轻。目前没有证据明确支持一种宏量营养素组成在用于减肥的饮食中具有优越性。主要作用似乎是对规定的热量减少的坚持程度。改变饮食行为的生活方式策略可用于个体咨询或团体咨询,这两者对于帮助患者改变饮食习惯都很重要。身体活动对于帮助患者在体重减轻后维持体重特别重要,而对于减肥本身的价值较小。食物摄入通过许多不同机制进行控制,但只有少数药物开发利用了这些机制。奥利司他可阻断肠道脂肪酶,是其中一种;西布曲明是一种5-羟色胺-去甲肾上腺素再摄取抑制剂,是另一种。手术方法能实现最显著的体重减轻,并且已被证明可降低长期死亡率并减少糖尿病发病率。

结论

许多方法都可以实现体重减轻,但手术程序似乎是最持久的。